Total testosterone is only one number on a hormone panel

What does a hormone panel measure besides total testosterone?

Longetic keeps each result next to the reference range the laboratory printed with it, which matters here because a panel is rarely one number. Alongside total testosterone, published guidelines describe free testosterone, SHBG, LH, FSH, prolactin, and a haemoglobin and haematocrit measurement. Each is ordered for a different reason, and that reason is printed in the guideline rather than on the report you are handed.

Total testosterone is the number most people are given. The Endocrine Society clinical practice guideline published in 2018 and the American Urological Association guideline approved the same year both treat it as a starting point rather than the whole answer. Both are written for clinicians. The Endocrine Society document says its recommendations "are developed to be of assistance to endocrinologists", and the AUA states that its goals are to "guide clinicians in how to assess patients for testosterone deficiency".

That audience is part of the fact. Almost everything about how these samples are taken, repeated and compared sits in documents written for the person ordering the test, not for the person having it.

Free testosterone is the fraction that is not bound to a carrier protein. The Endocrine Society puts the size of it plainly: "only 2.0% to 4.0% of circulating T is unbound or free", and "Most of the circulating T is bound to SHBG and albumin". On how to get at it, the guideline recommends "obtaining a free T concentration using either equilibrium dialysis or estimating it using an accurate formula", and notes that "Several different algorithms are available for calculating FT concentrations" without naming one as the standard.

SHBG is the carrier the guideline keeps pointing at. MedlinePlus, last updated 12 January 2026, says "SHBG is made mostly in your liver." and that sex hormones bound to it "cannot work with your tissues." It states the relationship in both directions and hedges both. Where SHBG is high, "it likely means that less of your total testosterone is available for your tissues to use." Where it is low, "it means that more of your total testosterone is likely free and available".

LH and FSH are the pituitary side of the panel. MedlinePlus says "In men, LH causes the testicles to make the hormone testosterone, which is important for making sperm." The Endocrine Society says measuring both "can help distinguish between primary and secondary hypogonadism", and the hedge in "can help" is the guideline's own. The AUA splits the two differently. It reads LH for the location, saying "A low or low/normal LH level points to a secondary (central) hypothalamic-pituitary defect", and that "an elevated LH level indicates a primary testicular defect". FSH it assigns to assessing "their underlying reproductive health status". Prolactin, in the AUA's wording, is measured in patients with low testosterone levels, and, as a separate part of the same sentence, "combined with low or low/normal luteinizing hormone levels".

Haemoglobin and haematocrit are the one item on the list that is not a hormone. The AUA's Statement 11 says "Prior to offering testosterone therapy, clinicians should measure hemoglobin and hematocrit", and, as a separate fragment of the same statement, "and inform patients regarding the increased risk of polycythemia". That is a measurement taken before anything is offered, which is why it belongs in a section about what the panel contains rather than in one about what a prescription can mean for repeat tests.

Why is the sample taken in the morning?

Every source read for this article agrees on the morning, and on little else about timing. The Endocrine Society recommends a morning measurement, MedlinePlus tells patients the sample is taken between 7 and 10 in the morning because levels are typically highest then, and an NHS trust laboratory handbook asks clinicians for a 9am collection because of diurnal variation. The agreement is about the time of day and stops there.

MedlinePlus, last updated 5 June 2025, is the plainest version for a reader: "Your provider will take a blood sample in the morning, between 7 and 10." It gives the reason in the next sentence, with a qualifier worth keeping: "During these hours, your testosterone levels are typically the highest." The MedlinePlus encyclopedia entry, which carries a review date of 25 January 2026 and licenses its content from A.D.A.M., puts it as "The best time for the blood sample to be taken is between 7 a.m. and 10 a.m."

On the clinician side in England, the Severn Pathology page at North Bristol NHS Trust says "In males, please collect samples at 9am due to effects of diurnal variation." Its free testosterone page repeats the same line. The same trust's guide to investigating suspected endocrine problems in males is less consistent with itself: in one place samples "should be measured before 11am", in another it asks for a "Morning TT (7am-11am, fasted sample)", and in a third for a "9am fasted sample due to diurnal variation". Three windows inside one document is a good reason not to quote any single number as the rule.

The patient-facing side of the same health service says none of this. The national NHS page on the male menopause notes that a GP "may also order a blood test to measure your testosterone levels." and says nothing at all about the time of day, about fasting, or about repeating the test. Its own printed dates have run out: the page prints "Page last reviewed: 13 October 2022" and "Next review due: 13 October 2025". The general NHS page on blood tests, reviewed on 2 November 2023 with the next review due on 2 November 2026, puts preparation on the clinician rather than on you: "The GP, nurse, or specialist should tell you if you need to do anything to prepare for a blood test."

Do the guidelines agree about fasting?

No, and the disagreement is the useful part. The Endocrine Society asks for a fasting morning sample, the American Urological Association states that its panel does not recommend insisting on fasting before testing, and MedlinePlus tells patients they may need to fast and to ask their provider. Two guidelines from the same year answer the question differently, so whether you fasted is worth recording rather than assumed.

The Endocrine Society's recommendation reads "We recommend measuring fasting morning total T concentrations", and its evidence section spells the same thing out: "clinicians should measure T concentrations in the morning after an overnight fast."

The AUA is explicit in the other direction. In its diagnosis section it says "the Panel does not recommend that clinicians insist on fasting prior to testing."

MedlinePlus keeps both doors open for the reader, with the qualifier intact: "you may need to fast (not eat or drink) for several hours before the test." It then hands the question back: "Ask your provider how you should prepare for a testosterone levels test."

This article is not telling you whether to fast. It is pointing out that the answer is a fact about your particular sample, that two respected guidelines disagree about it, and that the only person in a position to write it down is you. What eating or a hard session does to other blood results is a separate subject, and we have covered eating before a fasting test and training before a draw elsewhere.

Why would a doctor repeat a low result?

Because one low number is not treated as a finding. The Endocrine Society says it is important to confirm low concentrations, and its evidence section reports that 30% of men whose first result fell in the hypogonadal range had a normal result on repeat measurement. The AUA asks for two measurements taken on separate occasions, both early in the morning, before a diagnosis is made.

The Endocrine Society's evidence section says "It is important to confirm low T concentrations" and that "At least two T measurements were needed to diagnose T deficiency with confidence". The 30% figure sits in the same passage and is printed flatly, not as an approximation, and it describes men whose initial concentration fell in the hypogonadal range rather than first results in general. The recommendation is to confirm "by repeating the measurement of morning fasting total T concentrations."

The AUA's Statement 2 carries a strong recommendation at evidence level A. One part of it reads "The diagnosis of low testosterone should be made only after two total testosterone measurements". A separate part of the same statement reads "are taken on separate occasions with both conducted in an early morning fashion". The phrase "only after" is doing real work there.

The patient-facing version is gentler. MedlinePlus says "A second sample is often needed to confirm a result that is lower than expected." The clinician guide at North Bristol NHS Trust says "A level below the reference range on two occasions support the diagnosis of hypogonadism", and asks staff to "Repeat TT on a morning fasted sample".

If you are asked for a second sample, the thing worth writing down is which one you are giving. A first measurement and a confirmatory one are not interchangeable, and a year later nothing printed on either report will tell you which was which.

Does it matter which laboratory runs the test?

The AUA says it does: for measurements compared over time it asks for the same laboratory and the same assay, in those words. The Endocrine Society's nearest line is about the quality of the assay rather than about keeping it constant. Four NHS trust handbooks read for this article each print their own reference interval for the same analyte, and no two of them match.

The AUA's wording is short. Measurements should be taken "at the same laboratory using the same assay", and clinicians should "use the same laboratory with the same method/instrumentation for serial total testosterone measurement". The Endocrine Society does not say this in the text available to us. Its nearest equivalent is that "Clinicians should ideally measure TT using a CDC-certified assay", with the qualifier "ideally" in place, and that is a statement about assay quality rather than about using the same one twice.

What that instruction protects against is visible in the handbooks themselves. Four NHS trust pathology handbooks read for this article, all of them written for clinicians rather than patients, each print an adult male reference interval for total testosterone, and the intervals are not the same as each other. The same is true for SHBG. Calculated free testosterone is reported in nmol/L at one trust and in pmol/L at another. We are not reprinting any of those intervals here, because the point is not what any one of them says. The point is that the interval belongs to the laboratory that printed it, not to the test.

Two of the four print no date for their own content, which is a problem of its own when you are trying to work out how current a number is. North West London Pathology also states who its pages are for: "Results are communicated to clinical staff and are normally not communicated direct to patients", with the qualifier "normally" left in. For the general question of when a change between two results is a change, and for what happens to a figure when the units a laboratory prints are not the ones you are used to, we have separate pages.

What does the NHS App show of a result like this?

Less than most people expect. The NHS App help page on test results states plainly that results cannot be downloaded from the app, and tells patients to contact the GP surgery for a copy. The history graph it offers is conditional twice over: on the same test having been done at least twice in the past three years, and on the GP surgery itself.

The page, last reviewed on 13 January 2026 with the next review due on 13 July 2027, says "It is not possible to download your test results from the NHS App." The graph condition arrives as two separate sentences: "A graph will only be available if the same test has been done at least twice in the past 3 years", and "This feature is not available for all users, it depends on your GP surgery." The companion page on viewing test results, reviewed on 27 February 2024, adds "You can ask for your test results from your GP surgery."

This article makes no claim about where results from private providers do or do not appear. That is a separate question with a separate answer, and nothing here should be read as addressing it.

Can biotin change these results?

It can change some immunoassay results, and the direction depends on how the assay is built. A guidance document from ADLM, formerly the American Association for Clinical Chemistry, summarises studies in which biotin ingestion interfered with a list of tests that includes luteinising hormone and follicle stimulating hormone. One NHS trust handbook asks that samples not be taken within eight hours of a high biotin dose.

The ADLM guidance document, dated 13 January 2020 and headed "Recommendations to Laboratories and Clinicians", describes the mechanism running in two directions. "Excess biotin produces falsely low results in sandwich" assays, and "In competitive immunoassays, excess biotin causes falsely elevated results".

The list of affected tests comes from the document's summary of crossover studies in healthy volunteers given a single dose, at amounts far above what a general multivitamin contains. The tests named across consecutive fragments of that sentence include "free triiodothyronine [T3], thyroglobulin, dehydroepiandrosterone sulfate [DHEAS], estradiol, testosterone," and, at the end of the same list, "luteinizing hormone, and follicle-stimulating hormone [FSH])." That is a summary of study findings, not a statement that every result is affected every time.

Laboratories in England act on it regardless. University Hospitals Sussex, on handbook pages last updated 19 May 2026, asks that "Samples should not be taken from patients receiving therapy with high biotin doses", and, as a separate fragment, "until at least 8 hours following the last biotin administration." The same two lines appear on its SHBG page and on its LH page. The ADLM document also says laboratories "should also seek to inform patients of the potential for biotin interference".

Which means the thing the laboratory actually needs is a list of what you were taking on the day, and that list is yours to keep. Working through a long list of products one by one is a different job, and we have written about auditing a long list of products separately.

What is worth writing down, and what nobody asks you to write down

Four things decide whether two hormone results can be read against each other: the clock time of the draw, whether you had fasted, which laboratory ran it, and whether it was a first sample or a confirmatory one. Across eleven patient-facing pages read for this article in England and in Spain, none asks the patient to record the time of the draw, and none asks the patient to keep the laboratory's own interval.

The instruction does exist. It is simply addressed to somebody else. A manual on the preanalytical phase from the INGESA hospital in Ceuta, written for clinical staff and dated June 2007, says "Se debe registrar la hora exacta de la toma de muestra y enviar ésta al laboratorio en el contenedor adecuado." The duty to record the exact time of the sample sits with the person taking it. The same document gives the fasting instruction as a general recommendation rather than a rule: "Ayuno: como norma general se recomienda un ayuno de 8 horas previo a la extracción."

Spain's national patient-facing page on preparing for a medical visit, published by the Red de Escuelas de Salud para la Ciudadanía with a source date of 01/07/2015 and a Ministerio de Sanidad copyright line, asks for a great deal and comes closer than anything we read in England. It says "Haga una lista de todos sus medicamentos y pastillas", and, as a separate fragment, "o llévelos consigo". It asks the reader to "Escriba los detalles de sus síntomas, incluida la fecha en la que aparecieron", and to "Anote todo lo que ha hablado y lo que sucederá a continuación. Guarde sus notas". A medication list, symptoms with their dates, notes kept afterwards. Not the clock time of a blood draw, and not the laboratory's interval.

The only Spanish patient page we read that prints an extraction clock window is a hospital FAQ in the Comunidad de Madrid: "El horario de extracciones es de 7:30 h a 9:45 h, de lunes a viernes." That is a statement about when the phlebotomy room is open, not about diurnal variation, and it should not be read as one. A patient page in Castilla y León gives "Tiempo de ayunas: de 8 a 10 horas." and asks that "Es muy importante que respete el horario que se le ha asignado", again for queueing reasons rather than physiological ones.

The gap is small and entirely practical. The report arrives carrying a number and an interval printed by one laboratory. What it does not carry is the time you were drawn, whether you had eaten, or whether this was the first sample or the second. Longetic keeps reports from different laboratories in one line and shows each value next to your lab's own reference range, so the interval stays attached to the result it belongs to, and it keeps a medication list with reminders and a dose schedule, so what you were taking and the report sit in the same record. It does not interpret a result, does not convert units, does not check interactions, does not read an NHS GP record, and has no NHS login.

So the page you hand over is short. Write the date and the clock time of the draw. Write whether you had fasted, and for how long if you know. Write the name of the laboratory, and keep the report it issued rather than the number copied out of it. Write whether this was a first sample or a repeat. Write every medicine and every product you were taking that week, including anything containing biotin. Then ask your doctor the questions you actually came with, and let them read the interval the laboratory printed beside the number.

Frequently asked questions